RESEARCH USE ONLY. Reference data for laboratory research. Not medical advice; not for human consumption.
Peptijournal
Calc

Compare compounds

Pick up to 3 compounds to see protocols, mechanisms, study endpoints and safety findings side by side.

PopularRetatrutide vs TirzepatideSemaglutide vs TirzepatideSemaglutide vs RetatrutideBPC-157 vs TB-500BPC-157 vs GHK-CuSermorelin vs Tesamorelin
Cartalax
Same goal
Include when printing

Only affects the printed page / PDF. The research-use-only notice always prints.

Protocol01
Cartalax

Longevity

Vials · 10 / 20 mg

01Protocol

Vials
10 / 20 mg
Dosing data
Lab reference — not listed

02Quick calculator

Draw (100u)

—

Concentration

—

mg/mL

03Mechanism of action

Cartalax is described as the short peptide AED (Ala-Glu-Asp), one of the bioregulator peptides studied by Khavinson and colleagues for effects on gene expression in ageing cells.

04Study endpoints

  • In ageing human mesenchymal stem cell cultures, AED, KED and KE at nanomolar concentrations modulated expression of ageing-related genes, including NFκB.
  • A peptide mixture including AED promoted markers of neuronal differentiation in human periodontal ligament stem cells.

05Safety & regulatory findings

  • Not approved by the FDA or EMA for any indication; research-grade material is not a medicine.
  • Evidence is from cell culture studies, mostly from one research group; no controlled human trials are cited.

06Citations

2 references · view